airway protection during emergence
Conditions
Interventions
Group SD5:0.5 ug/kg dexmedetomidine
Group SD7:0.7 ug/kg dexmedetomidine
Group SR:0.03 ug/kg remifentanil
Sponsors
Shanghai Eye, Ear, Nose, and Throat Hospital, Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: All patients were American Society of Anesthesiologist physical status I and II, scheduled for elective otologic surgery
Exclusion criteria
Exclusion criteria: Patients with current upper respiratory infection, asthma, mental disease, or other congenital disease were not included. In addition, patients with hypertension, difficult airway, motion sickness, smoke, and allergic to parecoxib were also discarded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| smooth extubatio; | — |
Secondary
| Measure | Time frame |
|---|---|
| airway complications;awaike time;pain score;ponv; | — |
Countries
China
Contacts
Public ContactXia Shen
Outcome results
None listed